We are live on ! Find out more
JAMONY

Jacob Asset Management of New York Portfolio holdings

AUM $70.9M
1-Year Est. Return 14.28%
This Fund
S&P 500
This Quarter Est. Return
-0.57%
1 Year Est. Return
+14.28%
3 Year Est. Return
+22.72%
5 Year Est. Return
10 Year Est. Return
AUM
$275M
AUM Growth
-$27.9M
Cap. Flow
-$14.8M
Cap. Flow %
-5.37%
Top 10 Hldgs %
44.13%
Holding
85
New
3
Increased
36
Reduced
26
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 33.87%
2 Healthcare 27.65%
3 Communication Services 17.2%
4 Financials 6.95%
5 Industrials 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEJU
51
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$1.1M 0.4%
98,555
DMAC icon
52
DiaMedica Therapeutics
DMAC
$369M
$1.1M 0.4%
275,000
ATHX
53
DELISTED
Athersys, Inc. Common Stock
ATHX
$1.09M 0.4%
32,800
+4,000
+14% +$152K
MESO
54
Mesoblast
MESO
$2.18B
$1.04M 0.38%
86,200
-1,500
-2% -$20.8K
BMTX
55
DELISTED
BM Technologies, Inc.
BMTX
$979K 0.36%
110,000
+40,000
+57% +$409K
ICAD
56
DELISTED
iCAD Inc
ICAD
$895K 0.33%
83,260
-10,000
-11% -$130K
AKUS
57
DELISTED
Akouos Inc
AKUS
$882K 0.32%
76,000
-19,000
-20% -$228K
QUMU
58
DELISTED
Qumu Corp.
QUMU
$748K 0.27%
301,700
-556,100
-65% -$1.48M
HRTX icon
59
Heron Therapeutics
HRTX
$64.7M
$675K 0.25%
63,098
+21,098
+50% +$257K
RFL icon
60
Rafael Holdings
RFL
$103M
$655K 0.24%
21,598
SLE icon
61
Super League Enterprise
SLE
$5.44M
$653K 0.24%
22
AEO icon
62
American Eagle Outfitters
AEO
$2.72B
$614K 0.22%
23,800
+5,800
+32% +$184K
IIN
63
DELISTED
IntriCon Corporation
IIN
$581K 0.21%
32,000
ESPR
64
DELISTED
Esperion Therapeutics
ESPR
$573K 0.21%
47,534
-16,900
-26% -$246K
APLS
65
DELISTED
Apellis Pharmaceuticals
APLS
$530K 0.19%
16,088
+2,888
+22% +$162K
WRN
66
Western Copper and Gold
WRN
$543M
$522K 0.19%
350,000
IZEA icon
67
IZEA Worldwide
IZEA
$53.8M
$509K 0.19%
66,250
+8,750
+15% +$76.7K
XPL icon
68
Solitario Resources
XPL
$73.6M
$500K 0.18%
900,000
REED
69
DELISTED
Reeds, Inc. Common Stock
REED
$462K 0.17%
15,400
TWST icon
70
Twist Bioscience
TWST
$7.85B
$379K 0.14%
+3,543
New +$406K
TRHC
71
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$359K 0.13%
13,700
-88,200
-87% -$3.25M
AMRS
72
DELISTED
Amyris Inc.
AMRS
$315K 0.11%
+22,933
New +$328K
SDGR icon
73
Schrodinger
SDGR
$1.39B
$304K 0.11%
5,558
+2,158
+63% +$138K
CDNA icon
74
CareDx
CDNA
$2.45B
$300K 0.11%
4,729
+1,112
+31% +$84.7K
IMV
75
DELISTED
IMV Inc. Common Shares
IMV
$257K 0.09%
15,500
-4,500
-23% -$77.8K

Similar funds

Jacob Asset Management of New York's Q3 2021 Portfolio in Review

As of Q3 2021, Jacob Asset Management of New York held 85 positions worth $275M, down 9.2% from $303M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Jacob Asset Management of New York withdrew a net $14.8M in Q3 2021, closing 6 positions and reducing 26 holdings. Its most notable exit was SharpSpring, Inc., an estimated $10.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 35% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Jacob Asset Management of New York opened a new position in Twist Bioscience worth $379K.

  • Jacob Asset Management of New York's largest Q3 2021 buy was Twist Bioscience: 3,543 shares worth $379K.
  • Jacob Asset Management of New York added most to Identive in Q3 2021, an estimated $2.38M increase.
  • Jacob Asset Management of New York's biggest Q3 2021 reduction was Tabula Rasa HealthCare, Inc. Common Stock, cutting an estimated $3.25M.
  • Jacob Asset Management of New York fully exited SharpSpring, Inc. in Q3 2021, selling an estimated $10.6M.
  • Jacob Asset Management of New York's ten largest holdings make up 44% of its $275M portfolio in Q3 2021.
  • Jacob Asset Management of New York opened 3 new positions and closed 6 in Q3 2021.
  • Jacob Asset Management of New York's portfolio value fell 9.2% quarter-over-quarter to $275M.

Based on Jacob Asset Management of New York's 13F filing for Q3 2021, filed 12 Nov 2021.